相关实验视频
Updated: Jan 9, 2026

05:14
A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
Published on: May 16, 2020
5.3K
扩展性心肌病的死后诊断:一个系统性审查,重温基本原理
Simona Calabrese1, Vincenzo Cianci1, Daniela Sapienza1
1Department of Biomedical and Dental Sciences and Morphofunctional Imaging, Section of Legal Medicine, University of Messina, via Consolare Valeria, 1, 98125 Messina, Italy.
Diagnostics (Basel, Switzerland)
|December 11, 2025
概括
扩张性心肌病 (DCM) 可以导致心脏突然死亡. 尸检分析,包括遗传检测,对于诊断DCM至关重要,特别是在没有先前症状的年轻人中.
科学领域:
- 心血管病理学心血管病理学
- 法医医学 法医医学
- 遗传学 遗传学 是一个
背景情况:
- 扩张性心肌病 (DCM) 是一种心肌疾病,导致心腔扩大和功能受损.
- 它是心脏突然死亡的主要原因,通常在解剖之前未被诊断出来,特别是在年轻人中.
研究的目的:
- 系统地审查用于诊断扩张性心肌病 (DCM) 的死后发现.
- 为了确定关键的毛细,显微和遗传标记,用于死后的DCM诊断.
主要方法:
- 按照PRISMA指南进行系统的文献审查.
- 在PubMed和Scopus中搜索到2025年2月为止对死后DCM发现的研究.
- 包括报告DCM病例中的宏观,显微和遗传变异的研究.
主要成果:
- 常见的发现:心脏体重增加,心腔扩张,心脏壁薄化,纤维化,肌细胞缩.
- 经常发现的基因变异 (TTN,FLNC,DSP,PKP2,MYH7),特别是在年轻的死者中.
- 大约一半的审查研究中没有进行基因分析,这突显了诊断差距.
结论:
- 扩张性心肌病 (DCM) 可以导致没有先前症状的突然死亡.
- 基因检测对于诊断至关重要,特别是在阴性表型的情况下.
- 分子尸检与传统方法相结合,增强了对DCM的法医评估.
相关概念视频
Cardiomyopathy II: Dilated Cardiomyopathy
436
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
436
Cardiomyopathy V: Interprofessional Care
313
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
313
Cardiomyopathy I: Introduction and Classification
479
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
479
Cardiomyopathy III: Hypertrophic Cardiomyopathy
362
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
362
Cardiomyopathy IV: Restrictive Cardiomyopathy
426
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
426
Mitral Stenosis II: Clinical features and Diagnostic Tests
194
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
194

